Thromboprophylaxis With Dalteparin in Medical Patients: Which Patients Benefit?

Vascular Medicine - United Kingdom
doi 10.1177/1358863x07079017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Thromboprophylaxis for Trauma Patients

Cochrane Database of Systematic Reviews
2013English

Thromboprophylaxis in Cancer Patients-A Review

Scholars Journal of Applied Medical Sciences
2016English

Direct Oral Anticoagulants for Extended Thromboprophylaxis in Medically Ill Patients: Meta-Analysis and Risk/Benefit Assessment

Journal of Blood Medicine
Hematology
2018English

PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Transcatheter Mitral Valve Repair Using the MitraClip: Which Patients Benefit Most?

Wiener Klinische Wochenschrift
Medicine
2018English

Prolonged Thromboprophylaxis With Dalteparin After Surgical Treatment of Achilles Tendon Rupture: A Randomized, Placebo-Controlled Study

Journal of Orthopaedic Trauma
MedicineSurgeryOrthopedicsSports MedicineSports Science
2007English

Medical Treatment of Mammary Desmoid-Type Fibromatosis: Which Benefit?

World Journal of Surgical Oncology
SurgeryOncology
2017English

Thromboprophylaxis in Intensive Care Unit Patients: A Literature Review

Cureus
2018English

Clinical Intensity-Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Practical Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy